WallStreetZenWallStreetZen

NASDAQ: SCNX
Scienture Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SCNX

Based on 1 analyst offering 12 month price targets for Scienture Holdings Inc

Min Forecast
$1.50+228.23%
Avg Forecast
$1.50+228.23%
Max Forecast
$1.50+228.23%

Should I buy or sell SCNX stock?

Based on 1 analyst offering ratings for Scienture Holdings Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SCNX stock forecasts and price targets.

SCNX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-24

1 of 1

Forecast return on equity

Is SCNX forecast to generate an efficient return?

Company
24.56%
Industry
24.56%
Market
179.62%
SCNX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SCNX forecast to generate an efficient return on assets?

Company
19.37%
Industry
19.37%
SCNX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SCNX earnings per share forecast

What is SCNX's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.73
Avg 2 year Forecast
-$0.21
Avg 3 year Forecast
$0.23

SCNX revenue forecast

What is SCNX's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$5.2M+690.95%
Avg 2 year Forecast
$17.6M+2,587.67%
Avg 3 year Forecast
$38.7M+5,829.07%
SCNX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SCNX revenue growth forecast

How is SCNX forecast to perform vs Pharmaceutical Retailers companies and vs the US market?

Company
289.94%
Industry
289.94%
Market
13.42%
SCNX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SCNX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SCNX vs Pharmaceutical Retailer Stocks

TickerPricePrice TargetUp/downsideConsensus
SCNX$0.46$1.50+228.23%Strong Buy
RDGT$2.19N/AN/A
WGRX$0.12N/AN/A
HKPD$0.62N/AN/A
POM$0.36N/AN/A
View Top Pharmaceutical Retailer Stocks

Scienture Holdings Stock Forecast FAQ

Is Scienture Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SCNX) stock is to Strong Buy SCNX stock.

Out of 1 analyst, 1 (100%) are recommending SCNX as a Strong Buy, 0 (0%) are recommending SCNX as a Buy, 0 (0%) are recommending SCNX as a Hold, 0 (0%) are recommending SCNX as a Sell, and 0 (0%) are recommending SCNX as a Strong Sell.

If you're new to stock investing, here's how to buy Scienture Holdings stock.

What is SCNX's earnings growth forecast for 2026-2028?

(NASDAQ: SCNX) Scienture Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Pharmaceutical Retailers industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.93%.

Scienture Holdings's earnings in 2026 is -$20,554,663.On average, 3 Wall Street analysts forecast SCNX's earnings for 2026 to be -$29,839,271, with the lowest SCNX earnings forecast at -$28,669,103, and the highest SCNX earnings forecast at -$30,716,896. On average, 3 Wall Street analysts forecast SCNX's earnings for 2027 to be -$8,703,121, with the lowest SCNX earnings forecast at -$8,361,822, and the highest SCNX earnings forecast at -$8,959,095.

In 2028, SCNX is forecast to generate $9,531,989 in earnings, with the lowest earnings forecast at $9,158,186 and the highest earnings forecast at $9,812,342.

What is SCNX's revenue growth forecast for 2026-2028?

(NASDAQ: SCNX) Scienture Holdings's forecast annual revenue growth rate of 289.94% is not forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 289.94%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.42%.

Scienture Holdings's revenue in 2026 is $653,391.On average, 3 Wall Street analysts forecast SCNX's revenue for 2026 to be $209,980,052, with the lowest SCNX revenue forecast at $201,772,627, and the highest SCNX revenue forecast at $216,155,936. On average, 3 Wall Street analysts forecast SCNX's revenue for 2027 to be $713,517,742, with the lowest SCNX revenue forecast at $685,563,741, and the highest SCNX revenue forecast at $734,523,874.

In 2028, SCNX is forecast to generate $1,574,037,773 in revenue, with the lowest revenue forecast at $1,512,278,934 and the highest revenue forecast at $1,620,316,271.

What is SCNX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: SCNX) forecast ROA is 19.37%, which is lower than the forecast US Pharmaceutical Retailers industry average of 19.37%.

What is SCNX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SCNX price target, the average SCNX price target is $1.50, with the highest SCNX stock price forecast at $1.50 and the lowest SCNX stock price forecast at $1.50.

The Wall Street analyst predicted that Scienture Holdings's share price could reach $1.50 by Feb 24, 2027. The average Scienture Holdings stock price prediction forecasts a potential upside of 228.23% from the current SCNX share price of $0.46.

What is SCNX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: SCNX) Scienture Holdings's current Earnings Per Share (EPS) is -$8.38. On average, analysts forecast that SCNX's EPS will be -$0.73 for 2026, with the lowest EPS forecast at -$0.71, and the highest EPS forecast at -$0.76. On average, analysts forecast that SCNX's EPS will be -$0.21 for 2027, with the lowest EPS forecast at -$0.21, and the highest EPS forecast at -$0.22. In 2028, SCNX's EPS is forecast to hit $0.23 (min: $0.23, max: $0.24).

What is SCNX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: SCNX) forecast ROE is 24.56%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.